Related Experiment Videos
Creatine therapy for Huntington's disease: clinical and MRS findings in a 1-year pilot study
S J Tabrizi1, A M Blamire, D N Manners
1Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London, UK.
Neurology
|July 9, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Decoding Huntington's disease: a global survey on symptoms and genetic testing practices.
European archives of psychiatry and clinical neuroscience·2025
Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarker.
Parkinsonism & related disorders·2025
Evaluation of cerebrospinal fluid alpha-synuclein seed amplification assay in PSP and CBS.
medRxiv : the preprint server for health sciences·2024
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2023
Emotion dysregulation, impulsivity and anger rumination in borderline personality disorder: the role of amygdala and insula.
European archives of psychiatry and clinical neuroscience·2023
Mass Coral Reef Bleaching: A Recent Outcome of Increased El Niño Activity?
Ecology letters·2021
Pooled Analysis of Valve-in-Valve and Valve-in-Ring Transcatheter Mitral Valve Replacement Using the SAPIEN Valve.
Journal of the American Heart Association·2026
tRNA‑derived RNAs in hepatic diseases: From biological functions to clinical translation (Review).
International journal of molecular medicine·2026
Carotid stent infection caused by Burkholderia pseudomallei successfully treated with surgery.
Journal of vascular surgery cases and innovative techniques·2026
FP003B suppresses microcarrier aggregation and enhances cell yield in microcarrier-based mesenchymal stromal cell culture.
Frontiers in bioengineering and biotechnology·2026
First-line biologic and targeted synthetic DMARDs versus methotrexate in early rheumatoid arthritis: a meta-analysis of remission outcomes.
Rheumatology (Oxford, England)·2026